The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.

Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...

This episode is sponsored by Endel, an app that creates personalized soundscapes to help you focus, relax and sleep. Could you enter a flow state with the people around you? Also, we've found a ...

Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight.

In 2019, a research group led by Andrés Ozaita, of the Department of Medicine and Life Sciences at Pompeu Fabra University, ...

The review synthesizes evidence on whether Alzheimer’s disease medications can improve neurocognitive outcomes in children ...

An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. The drug dupilumab (Dupixent) effectively clears up airways ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits their availability for those who need them. Part of the reason for the cost ...

As the popularity of GLP-1 receptor agonists for weight loss continues to grow, researchers continue to examine how these medications might impact other areas of a person’s health. In 2023, published ...

Share on Pinterest A new study finds that GLP-1 drugs’ heart health benefits may not be solely due to weight loss. The Good Brigade/Getty Images As the popularity of GLP-1 receptor agonists for weight ...

Oct 24 (Reuters) - A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported at a major European oncology ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...